Medical Weight Loss
WEIGHT LOSS THAT WORKS WITH YOUR BIOLOGY
GLP-1 receptor agonists — including Semaglutide (Wegovy / Ozempic) and Tirzepatide (Mounjaro / Zepbound) — represent the most significant advance in metabolic medicine in decades. At LUMUS, our physician-supervised GLP-1 program is designed for patients who want medically sound, long-term weight management — not quick fixes.
Available via Telehealth • Serving All of California
The Mechanism
THE SCIENCE BEHIND GLP-1
GLP-1 (glucagon-like peptide-1) is a hormone naturally produced in the gut that signals fullness to the brain, slows gastric emptying, and regulates blood sugar. GLP-1 receptor agonists like Semaglutide and Tirzepatide mimic and amplify this signal — reducing appetite, decreasing caloric intake, and improving metabolic function — without the willpower battles of conventional approaches.
Clinical trials show average weight loss of 15–22% of body weight over 68 weeks — significantly more effective than any previously available non-surgical intervention.
The Whole Person
WEIGHT, MOOD, AND THE WHOLE PERSON
At LUMUS, we see what other weight loss programs often miss: obesity, depression, anxiety, and metabolic dysfunction are deeply connected — biologically, hormonally, and neurologically.
Our GLP-1 program is offered by the same board-certified psychiatrist who leads our ketamine and mental health services — meaning your weight loss care can be fully integrated with any psychiatric treatment you're receiving.
Your Journey
OUR PROGRAM
Medical Consultation
In-person or telehealth evaluation to determine eligibility, review medical history, and create a personalized treatment plan.
Prescription & Dosing
Medication prescribed and titrated for your starting point and goals. Sent to preferred or compounding pharmacy.
Ongoing Monitoring
Regular check-ins to monitor progress, manage side effects, and adjust dosing.
Integrated Support
Nutritional guidance, activity recommendations, and psychiatric support if relevant — all from the same clinical team.
What We Prescribe
AVAILABLE MEDICATIONS
Semaglutide
FDA-approved for chronic weight management. Weekly injection. Average 15% body weight reduction in clinical trials. Available as brand-name or compounded.
Tirzepatide
Dual GIP/GLP-1 agonist with up to 22% average body weight reduction in trials. Weekly injection. Available for eligible patients.
Common Questions
FREQUENTLY ASKED QUESTIONS
Ready to work with your biology, not against it?
Schedule your weight loss consultation — in-person in Corona or via telehealth anywhere in California.
Results vary. GLP-1 medications are not appropriate for everyone. A full medical evaluation is required prior to prescribing.